WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke Priavoid wurde als Wortmarke am 20.06.2017 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1388277 |
| Registernummer | 302017100346 |
| Länder | 
|
| Basismarke |
Nr. 30 2017 100 346,
10. März 2017
|
| Anmeldedatum | 20. Juni 2017 |
| Ablaufdatum | 20. Juni 2027 |
Markeninhaber
Theodor-Heuss-Str. 179
52428 Jülich
DE
52428 Jülich
DE
Markenvertreter
Kaiserswerther Str. 183
40474 Düsseldorf
DE
Waren und Dienstleistungen
01
Chemical substances for the production of pharmaceuticals;
esters of fatty acids for use in pharmaceuticals;
preservatives for pharmaceutical compounds; antimicrobial
preservatives for pharmaceutical compounds; chemicals for
the preparation and production of pharmaceuticals;
antioxidants for the production of pharmaceutical products;
chemical compounds for the preparation of pharmaceutical
products; esters for the production of pharmaceutical
products; preservatives for use in the pharmaceutical
industry; softening agents for the use during the
preparation of pharmaceuticals; chemical products for use in
the pharmaceutical industry; active chemical ingredients for
the use during the preparation of pharmaceuticals;
biochemical compounds for scientific purposes; biochemical
products, namely polypeptides for in vitro research
applications; biochemical products, namely, chemical
reagents for in vitro genetic technology; reagents for use
in scientific apparatus for chemical and biological
analysis; diagnostic reagents for in vitro use in
biochemistry, clinical chemistry and microbiology;
biochemicals, namely, monoclonal antibodies for in vitro
scientific or research use
05
Pharmaceuticals against allergies and for the abatement of
burns; drug delivery agents in the form of capsules that
provide controlled release of the active ingredients for a
wide variety of pharmaceuticals; pharmaceuticals;
implantable pharmaceuticals; serotherapeutic
pharmaceuticals; pharmaceutical drugs; medicated throat
sprays; medicine for dental purpose; medicine for veterinary
purpose; medicine for intestinal diseases; pharmaceutical
preparations for human purposes; pharmaceuticals for the
treatment of the autonomic nervous system; pharmaceuticals
for the treatment of gastrointestinal diseases;
pharmaceutical compounds and products; chemical and
pharmaceutical products and preparations for medical
purposes; antiepileptic pharmaceutical preparations;
pharmaceutical compounds and substances; chemical compounds
for pharmaceutical purpose; pharmaceutical agents for
metabolism; pharmaceutical agents for the intestines;
pharmaceutical compounds for human use; synthetic peptides
for pharmaceutical purpose; pharmaceutical agents and
compounds for the peripheral nervous system; pharmaceutical
products for the treatment of infections; pharmaceutical
products for the treatment of hyperlipidemias; crystals for
therapeutical purpose (pharmaceutical products);
pharmaceutical compounds for the prevention and treatment of
metabolic disorder; pharmaceutical compounds for the
treatment of kidney diseases; pharmaceutical compounds for
the prevention and treatment of metabolic diseases;
chemicals for pharmaceutical use; pharmaceutical compounds
for the treatment of a chemical imbalance; pharmaceutical
preparations for the central nervous system; pharmaceutical
compounds for the treatment of diabetes; pharmaceutical
compounds for the treatment of parkinson disease;
pharmaceutical compounds for the treatment of multiple
sclerosis; pharmaceutical compounds and substances for the
prevention of cancer; pharmaceutical compounds and
substances with analgesic properties; pharmaceutical
compounds for the treatment of epilepsy, disorders of the
intestines and of the sensory organs; pharmaceutical
compounds for the prevention of disorders and diseases of
the nervous system; pharmaceutical compounds and substances
for the treatment of cancer and cardiovascular diseases;
pharmaceutical compounds and substances for the use in
oncology; pharmaceutical products and substances for the
treatment of gastrointestinal diseases; pharmaceutical
compounds for the treatment of diseases of the central
nervous system (CNS); biological preparations for veterinary
and medical purposes; biological compounds for the treatment
of cancer; biochemical compounds for the treatment of cancer
and for medical purpose; biotechnological compounds for
medical purpose; diagnostic biomarker reagents for medical
purpose; bio-pharmaceuticals for the treatment of cancer
42
Development of pharmaceutical compounds and drugs; research
and development of vaccine and drugs; pharmaceutical product
development in relation to drugs; pharmaceutical research,
research regarding pharmaceuticals; conducting of quality
control tests on pharmaceutical products; medical and
pharmaceutical research services; pharmaceutical research
and development services; pharmaceutical research and
development; development of pharmaceutical products;
evaluation of results from quality control tests conducted
on goods and services in relation to pharmaceutical
products; consulting with regard to pharmacology; laboratory
research services with regard to pharmaceuticals; research
in the field of pharmaceuticals; consulting with regard to
pharmaceutical research and development; scientific research
in the field of pharmacy; pharmaceutical product evaluation,
namely services for the evaluation of the therapeutic
effects of pharmaceuticals; research and development
services for the pharmaceutical industry; research and
development in the field of pharmacy and biotechnology;
information technology [IT] consultancy services for
pharmaceutical industry and health sector; quality
assessment with regard to research in the field of
pharmacogenetics; biochemical research; biological research;
biological analysis; biological research services;
biological development services; biological laboratory
services; biochemical analysis; biomedical research;
biotechnological research; research regarding
biotechnologies; biotechnological research services;
scientific research regarding biology; biological research
and analysis; research in the field of biotechnology;
consulting in the field of biology; consulting in the field
of biochemistry; research and development in the field of
biochemistry; research and development services in the field
of biotechnology
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 31. Januar 2019 | 2019/6 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 04. Dezember 2018 | 2018/49 Gaz | CH | Ablehnung |
| 10. Juli 2018 | 2018/28 Gaz | EM | Ablehnung |
| 03. März 2018 | 2018/10 Gaz | US | Ablehnung |
| 20. Juni 2017 | 2018/4 Gaz | DE | Eintragung |
ID: 141388277